5- (4- (trimethylammonium)phenyl)- 10,15,20- tris(2,4,6- trimethoxyphenyl)porphyrin

structure in first source

Also Known As:

5-(4-(trimethylammonium)phenyl)-10,15,20-tris(2,4,6-trimethoxyphenyl)porphyrin iodide; 5-(4-trimethylammoniumphenyl)-10,15,20-tris(2,4,6-trimethoxyphenyl)porphyrin; CP compound; TTTPI cpd

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Costell, Melissa H: 1 article (01/2013)
2.	Cui, Jianqi: 1 article (01/2013)
3.	Harpel, Mark R: 1 article (01/2013)
4.	Hong, Victor S: 1 article (01/2013)
5.	Krosky, Daniel J: 1 article (01/2013)
6.	Schnackenberg, Christine G: 1 article (01/2013)
7.	Willette, Robert N: 1 article (01/2013)
8.	Wu, Charlene W: 1 article (01/2013)
9.	Yue, Tian-Li: 1 article (01/2013)
10.	Alvarez, M Gabriela: 1 article (12/2005)

Related Diseases

1.	Glucose Intolerance 01/01/2013 - "In obese SHR-cp, compound 11 significantly decreased mean arterial pressure, glucose intolerance, insulin resistance, hypertriglyceridemia, and plasma renin activity with no effect on heart rate, body weight gain, or microalbuminuria. "
2.	Hypertriglyceridemia 01/01/2013 - "In obese SHR-cp, compound 11 significantly decreased mean arterial pressure, glucose intolerance, insulin resistance, hypertriglyceridemia, and plasma renin activity with no effect on heart rate, body weight gain, or microalbuminuria. "
3.	Insulin Resistance 01/01/2013 - "In obese SHR-cp, compound 11 significantly decreased mean arterial pressure, glucose intolerance, insulin resistance, hypertriglyceridemia, and plasma renin activity with no effect on heart rate, body weight gain, or microalbuminuria. "
4.	Carcinoma (Carcinomatosis) 12/01/2005 - "The photokilling activity of 5-(4-trimethylammoniumphenyl)-10,15,20-tris(2,4,6-trimethoxyphenyl)porphyrin (CP) was evaluated on a Hep-2 human larynx-carcinoma cell line. "
5.	Body Weight (Weight, Body) 01/01/2013 - "In obese SHR-cp, compound 11 significantly decreased mean arterial pressure, glucose intolerance, insulin resistance, hypertriglyceridemia, and plasma renin activity with no effect on heart rate, body weight gain, or microalbuminuria. "

Related Drugs and Biologics

1.	Renin